Search

everythinglearnresearchcommunity

for

Search:↓

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Effective PCOS treatments require targeting specific signaling pathways.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Aromatase gene variation may increase female hair loss risk.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

A man with testotoxicosis was fertile despite low FSH levels, suggesting high testosterone may allow sperm production without FSH.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.